N/A Completed N=162 Treatment

Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).

Cataract

Source: ClinicalTrials.gov NCT00758745 ↗

Enrolled (actual)

162

Serious AEs

0.0%

Results posted

Jul 2011

Primary outcomePrimary: Posterior Capsule Opacification (PCO) — 0.18; 0.15 Units on a scale

Summary

Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).

Outcome Measures

Outcome	Result	p-value
PRIMARY Posterior Capsule Opacification (PCO)	0.18; 0.15	—

Eligibility Criteria

Inclusion Criteria

Age > 50 years
Clear cornea
Pupil mydriasis ≥ 7mm
In the bag Intraocular Lens (IOL)

Exclusion Criteria

Ocular pathology - uveitis, glaucoma, pseudoexfoliation syndrome (PEX), high myopia
Previously operated eye
Proliferative diabetic retinopathy
Surgical complications - incomplete rhexis, post capsular rupture (PCR), zonular dialysis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00758745). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.